Cytek Biosciences, Inc. (CTKB) Revenue Growth
Cytek Biosciences, Inc. (CTKB) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 28.20% |
| 2023-12-31 | 17.67% |
| 2024-12-31 | 3.85% |
| 2025-12-31 | 0.52% |
How CTKB compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BRKR | Bruker Corporation | 2.08% |
| MRK | Merck & Company Inc. | 1.31% |
| ALGN | Align Technology Inc. | 0.90% |
| BMY | Bristol-Myers Squibb Company | -0.22% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
These are five companies in the same sector as CTKB with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cytek Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CTKB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CTKB | $5.30 | +1.73% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 |